|

UTD1 combined with capecitabine Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Hunan Cancer Hospital1

Indications

  • UDT11
  • Capecitabine1
  • Metastatic HER2 Negative Breast Carcinoma1
  • Brain Metastases1
  • Breast Cancer1

Other1 trial

UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain Metastases
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.